Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-15.59	15.83	18.76
Graham Fair Price	27.18	40.74	32.04
PEG	43.87	0.07	-0.05
Price/Book	-23.00	0.77	1.00
Price/Cash Flow	35.10	-10.48	7.75
Prices/Earnings	-44.34	3.44	6.18
Price/Sales	-28.25	2.00	2.79
Price/FCF	35.10	-10.48	7.75
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-3.01	0.60	0.62
Operating Margin	-4.60	0.24	0.25
ROA	53.91	0.02	0.01
ROE	0.04	0.06	38.34
ROIC	0.03	0.03	-2.14
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.03	-0.06	-40.57
Dividends QOQ	2.75	-1.00	-63.64
EBIT QOQ	1.84	0.11	-94.18
EPS QOQ	1.29	0.50	-61.31
FCF QOQ	1.25	-1.62	29.21
Revenue QOQ	0.15	0.16	9.15
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	279.81	221.37	-20.89
Days Sales Outstanding (DSO)	94.84	116.34	22.67
Inventory Turnover	0.32	0.41	26.40
Debt/Capitalization	0.57	0.57	-1.05
Quick Ratio	0.78	0.87	11.26
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	33.52	36.24	8.13
Cash	10.78	9.08	-15.77
Capex	-1.01	-0.45	55.22
Free Cash Flow	4.34	-2.67	-38.37
Revenue	12.07	14.01	16.04
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.26	1.31	4.15
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	10.14	9.53	-6.07
Naive Interpretation	Member

06 - Financial Health · Weak

Rating